The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Exchanges
00:00
The Future of Anti-Obesity Drugs and the Next Breakthrough in the Market
This chapter explores the potential for oral anti-obesity drugs to replace injectables and discusses the investments being made by companies like Lily and Novo. It also highlights key indicators to monitor and the importance of conducting primary research to understand the impact of these drugs.
Transcript
Play full episode
